Domestication and characterization of TM7-the most elusive oral phylum

TM7——最难以捉摸的口腔门的驯化和表征

基本信息

  • 批准号:
    10559532
  • 负责人:
  • 金额:
    $ 48.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-03-01 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Abstract The overall goal of this application is to characterize newly discovered ultra-small parasitic bacteria that have extremely reduced genomes and show increased abundance in gingivitis and periodontitis. In the previous funding cycle, we successfully cultivated and sequenced TM7x, the first member of the uncultivated TM7 phylum from humans. Strain TM7x is unique among all bacteria, it has an ultrasmall size (200-300 nm) and lives on the surface of a host bacterium, a relationship that had never been reported in the human microbiome or in the Bacteria domain. With a highly-reduced genome, TM7x cannot synthesize any of its own amino acids, vitamins or cell wall precursors and must parasitize other oral bacteria which impacts their growth. Of particular note is that TM7 belongs to the Candidate Phyla Radiation (CPR), a recently discovered subdivision in the domain Bacteria that comprises >26% of the known bacterial diversity with an estimated 70 uncultivated Phyla with reduced genomes. To date, TM7x is still the only reported cultivated representative of the entire CPR, putting our team in a unique position to make significant advancements in the field and facilitate fundamental discoveries on these ultra-small human associated bacteria, as well as the CPR group as a whole. Our preliminary data revealed that the relationship of TM7x and its bacterial host, an oral Actinomyces odontolyticus strain XH001 is a highly-regulated symbiotic interaction in which TM7x displays both symbiotic phase (co-existing with host) and virulent parasitic phase (inducing host cell death). This intriguing relationship is similar to the one observed for temperate bacteriophages and their hosts where phages are capable of switching between lysogenic and lytic cycle, and entails physiological and ecological consequences. In this application, we aim to achieve the following two goals. 1) To identify the molecular components and regulatory pathways governing the relationship between TM7x and its host; 2) To investigate the range of bacteria that TM7x interacts with. In particular, the mechanism of host killing encoded within a bacterial parasite with a reduced genome is both fundamentally novel and clinically relevant. The ability to infect and kill multiple bacterial hosts may allow TM7x to influence the oral community dynamics and structure, thus modulating community and impacting microbiome during health and diseases. The success of the study would greatly advance the developing research field of these ultra-small bacteria, expand our knowledge on this novel microbial symbiosis found in humans, as well as the potential impact of CPR organisms on oral microbiome ecology.
抽象的 该应用的总体目标是表征新发现的具有的超小寄生细菌 基因组极大减少,并显示出牙龈炎和牙周炎的丰度增加。在上一个 融资周期,我们成功地培养和测序了TM7X,这是未经文化的TM7的第一个成员 人类的门。菌株TM7X在所有细菌中都是独特的,它具有超巨大的大小(200-300 nm),并且 生活在宿主细菌的表面,这种关系从未在人类微生物组中报道过 或在细菌域中。 TM7X具有高度降低的基因组,无法合成其自身的任何氨基酸, 维生素或细胞壁前体,必须寄生其他口服细菌,从而影响其生长。特别 请注意,TM7属于候选门(CPR),这是最近发现的细分 域细菌占已知细菌多样性的26%,估计为70个未培养的门 基因组减少。迄今为止,TM7X仍然是整个CPR中唯一报告的培养代表 使我们的团队处于独特的位置,以在该领域取得重大进步并促进基本 这些超小型人相关细菌以及整个心肺复苏群体的发现。 我们的初步数据表明,TM7X及其细菌宿主的关系是口服放线菌的关系 odontolyticus菌株XH001是一种高度调节的共生相互作用,其中TM7X显示两个共生 相(与宿主共存)和毒性寄生相(诱导宿主细胞死亡)。这种有趣的关系 类似于温带噬菌体及其宿主观察到的噬菌体能够 在溶菌发生和裂解周期之间切换,并需要生理和生态后果。在这个 应用,我们旨在实现以下两个目标。 1)确定分子成分和调节 管理TM7X与其主机之间关系的途径; 2)研究细菌的范围 TM7X与。特别是,宿主杀死的机制在细菌寄生虫中编码 减少的基因组既有新颖,又是临床上的。感染和杀死多重的能力 细菌宿主可以允许TM7X影响口腔社区的动态和结构,从而调节 在健康和疾病期间,社区和影响微生物组。 这项研究的成功将大大推动这些超小细菌的发展研究领域, 扩展我们对人类发现的新型微生物共生的知识,以及 CPR生物学生物学生态学。

项目成果

期刊论文数量(52)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rapid evolution of decreased host susceptibility drives a stable relationship between ultrasmall parasite TM7x and its bacterial host.
Phenotypic and Physiological Characterization of the Epibiotic Interaction Between TM7x and Its Basibiont Actinomyces.
  • DOI:
    10.1007/s00248-015-0711-7
  • 发表时间:
    2016-01
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Bor B;Poweleit N;Bois JS;Cen L;Bedree JK;Zhou ZH;Gunsalus RP;Lux R;McLean JS;He X;Shi W
  • 通讯作者:
    Shi W
Human variation in gingival inflammation.
Quorum Sensing Modulates the Epibiotic-Parasitic Relationship Between Actinomyces odontolyticus and Its Saccharibacteria epibiont, a Nanosynbacter lyticus Strain, TM7x.
  • DOI:
    10.3389/fmicb.2018.02049
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Bedree JK;Bor B;Cen L;Edlund A;Lux R;McLean JS;Shi W;He X
  • 通讯作者:
    He X
Host translation machinery is not a barrier to phages that interact with both CPR and non-CPR bacteria.
  • DOI:
    10.1128/mbio.01766-23
  • 发表时间:
    2023-12-19
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Liu, Jett;Jaffe, Alexander L.;Chen, Linxing;Bor, Batbileg;Banfield, Jillian F.
  • 通讯作者:
    Banfield, Jillian F.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xuesong He其他文献

Xuesong He的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xuesong He', 18)}}的其他基金

Diversity supplement for R01DE029479-01A1 to support Dr. Jeremy Elias
R01DE029479-01A1 的多样性补充品以支持 Jeremy Elias 博士
  • 批准号:
    10648830
  • 财政年份:
    2022
  • 资助金额:
    $ 48.27万
  • 项目类别:
Host tRNA-derived small RNAs (tsRNAs) mediate interactions between host and oral microbes
宿主 tRNA 衍生的小 RNA (tsRNA) 介导宿主和口腔微生物之间的相互作用
  • 批准号:
    10446416
  • 财政年份:
    2022
  • 资助金额:
    $ 48.27万
  • 项目类别:
Host tRNA-derived small RNAs (tsRNAs) mediate interactions between host and oral microbes
宿主 tRNA 衍生的小 RNA (tsRNA) 介导宿主和口腔微生物之间的相互作用
  • 批准号:
    10577837
  • 财政年份:
    2022
  • 资助金额:
    $ 48.27万
  • 项目类别:
pH-sensitive materials responding to metabolic activities of cariogenic plaque
响应致龋菌斑代谢活动的 pH 敏感材料
  • 批准号:
    10457152
  • 财政年份:
    2021
  • 资助金额:
    $ 48.27万
  • 项目类别:
Preventing dental caries through targeted treatment of acid-producing bacteria
通过针对性治疗产酸菌预防龋齿
  • 批准号:
    10896092
  • 财政年份:
    2021
  • 资助金额:
    $ 48.27万
  • 项目类别:
Oral Microbiome: Beyond Bacteria
口腔微生物组:超越细菌
  • 批准号:
    10318787
  • 财政年份:
    2021
  • 资助金额:
    $ 48.27万
  • 项目类别:
Preventing dental caries through targeted treatment of acid-producing bacteria
通过针对性治疗产酸菌预防龋齿
  • 批准号:
    10474963
  • 财政年份:
    2021
  • 资助金额:
    $ 48.27万
  • 项目类别:
pH-sensitive materials responding to metabolic activities of cariogenic plaque
响应致龋菌斑代谢活动的 pH 敏感材料
  • 批准号:
    10043261
  • 财政年份:
    2020
  • 资助金额:
    $ 48.27万
  • 项目类别:
Studying the Protective Effects of Normal Oral Flora
研究正常口腔菌群的保护作用
  • 批准号:
    9982063
  • 财政年份:
    2018
  • 资助金额:
    $ 48.27万
  • 项目类别:
Studying the Protective Effects of Normal Oral Flora
研究正常口腔菌群的保护作用
  • 批准号:
    9323373
  • 财政年份:
    2016
  • 资助金额:
    $ 48.27万
  • 项目类别:

相似国自然基金

低蛋白日粮脂肪和蛋白质互作影响氨基酸消化率的机制
  • 批准号:
    32302793
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
关键非催化氨基酸残基影响新型GH43家族双功能酶底物特异性的机制研究
  • 批准号:
    32301052
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
影响植物磷砷选择性吸收关键氨基酸位点的挖掘及分子机制研究
  • 批准号:
    42307009
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
  • 批准号:
    82370790
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目

相似海外基金

Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
  • 批准号:
    10678341
  • 财政年份:
    2023
  • 资助金额:
    $ 48.27万
  • 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
  • 批准号:
    10696538
  • 财政年份:
    2023
  • 资助金额:
    $ 48.27万
  • 项目类别:
Biophysical, Structural, and Cellular Dissection of COPI-Dependent Retrograde Trafficking Using a Coronavirus Toolkit
使用冠状病毒工具包对 COPI 依赖性逆行贩运进行生物物理、结构和细胞解剖
  • 批准号:
    10646999
  • 财政年份:
    2023
  • 资助金额:
    $ 48.27万
  • 项目类别:
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
  • 批准号:
    10643012
  • 财政年份:
    2023
  • 资助金额:
    $ 48.27万
  • 项目类别:
Development and Production of Standardized Reference Diets for Zebrafish Research
斑马鱼研究标准化参考饲料的开发和生产
  • 批准号:
    10823702
  • 财政年份:
    2023
  • 资助金额:
    $ 48.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了